Skip to main content

Part of the book series: CMR Workshop Series ((CMRW))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Anon (1986). Guideline for clinical evaluation of antihypertensive drugs. In: Guidelines for Clinical Evaluation of New Drugs. Yakugyo Jiho Co. Ltd, Tokyo.

    Google Scholar 

  • Clare, A (1989). National variations in medical practice. Br Med J, 298:1334.

    Article  CAS  Google Scholar 

  • Hirokawa K and Dollery CT (1994). The top 50 drugs in the UK and Japan: why are they so different? In: Walker SR, Lumley CE and McAuslane JAN (eds) The Relevance of Ethnic Factors in the Clinical Evaluation of Medicines. Kluwer Academic Publishers, Lancaster, pp. 63–88.

    Chapter  Google Scholar 

  • Harvey C, Lumley CE and Walker SR (1993). A comparison of the review of a cohort of NCEs by four national regulatory authorities. J Pharm Med, 3:65–75.

    Google Scholar 

  • Homma M (1992). Requirements for assessment of clinical safety regulatory perspectives. In: D’Arcy PF and Harron DWG (eds) Proceedings of The First International Conference on Harmonisation, Brussels, 1991. The Queen’s University of Belfast, pp. 390–399.

    Google Scholar 

  • MHW (1992). Guidelines on Statistical Analysis of Clinical Trials. Ministry of Health and Welfare, Japan.

    Google Scholar 

  • Naito C (1994). Evaluation methods for clinical trials of drugs in Japan which may affect ethnic differences. In: Walker SR, Lumley CE and McAuslane JAN (eds) The Relevance of Ethnic Factors in the Clinical Evaluation of Medicines. Kluwer Academic Publishers, Lancaster, pp. 4962.

    Google Scholar 

  • Payer L (1988). Medicine and Culture. Henry Holt & Co., New York.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Henderson, J. (1994). Medical practice differences between Europe, the United States and Japan. In: Walker, S., Lumley, C., McAuslane, N. (eds) The Relevance of Ethnic Factors in the Clinical Evaluation of Medicines. CMR Workshop Series. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-1420-2_7

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-1420-2_7

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-4621-3

  • Online ISBN: 978-94-011-1420-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics